new semaglutide medication Exploring the Latest Breakthroughs in Weight Loss Medication: Zepbound and Wegovy: Michelle Hamidi, MD: Family Medicine Physician Novo Nordisk to Seek Approval

Anti-obesity medications

According to NICE guidance (NG28), GLP-1 receptor agonists like Ozempic are typically considered when triple therapy is ineffective, not tolerated or contraindicated, with specific BMI and clinical criteria

Unlike phentermine (a stimulant), GLP-Squared avoids cardiovascular overstimulation while delivering synergistic appetite suppression through GLP-1 and GIP receptors

Body composition estimates Using only tape-measure inputs (waist, hips, etc.), get body fat percentage, lean body mass (LBM) and BMI without scales

However, collagen supplements are most effective when combined with a nutritious diet, sun protection, and a consistent skincare routine